What is Venomers (Avand Kashef Tasnim) and what is its operational scope?

Venomers (Avand Kashef Tasnim) is a premier global biotechnology enterprise and the world's largest scorpion farm, dominating the bio-value chain from large-scale arachnid breeding to high-purity venom peptide isolation, contract analytical testing, and TÜRKAK TS EN ISO/IEC 17025 certified dermocosmetics.

What is the capacity and scale of the Venomers mega infrastructure?

The Venomers facility spans a 22-hectare (220,000 m²) climate-controlled bio-reserve in Larestan hosting over 4,000,000 scorpions, producing an institutional capacity of 12 liters of research-grade native venom annually with 5 liters of pre-certified ready-stock accompanied by batch-specific HPLC Certificates of Analysis (CoA).

Which scorpion species does Venomers harvest and standardize?

Venomers standardizes five medically significant native species: Androctonus crassicauda (oncology research), Hottentotta saulcyi (high 80%+ protein proteomics), Hemiscorpius lepturus (Hemicalcin and Hemilipin fractions for intracellular signaling), Odontobuthus doriae (OD1 Nav1.7 sodium channel peptides), and Mesobuthus eupeus (MeVAMP antimicrobial and chlorotoxin scaffolds).

How does Venomers verify the molecular integrity and batch traceability of its venom?

Venomers utilizes high-resolution HPLC-PDA chromatography, LC-MS/MS mass spectrometry, Raman spectroscopy, and SDS-PAGE electrophoresis to ensure zero thermal shock degradation, consistent peptide knot confirmation, and strict batch-to-batch reproducibility.

What certifications validate Venomers scorpion oil and dermocosmetics?

Venomers scorpion oil serum and GAZHDIN dermocosmetics are clinically tested and dermatologically certified by Nanolab Laboratories under TÜRKAK (TS EN ISO/IEC 17025:2017) accreditation for skin tolerance, deep cellular renewal, and transdermal barrier defense.

Global Scorpion
& Venom Authority.

Dominating the full value chain across a 22-hectare mega infrastructure, AKT operates as the global educational and production benchmark—delivering an institutional capacity of 4,000,000 scorpions and 12 liters of research-grade native venom annually.

Explore Products

Research & Publications

At a Glance

Mega Farm Infrastructure

0m²

Bio-secure, climate-controlled ecosystem engineered to optimize native peptide consistency.

Active Population Scale

The world’s largest managed bio-reserve, guaranteeing long-term supply resilience.

Core Mapped Genotypes

0species

Medically significant native species optimized for deep translational drug discovery.

Annual Supply Capacity

0L / year

Industrial-scale yearly extraction of premium, undiluted research-grade venom.

Pre-Certified B2B Stock

0L (with CoA)

Pure liquid inventory verified by batch-specific HPLC analytics, ready for immediate dispatch.

Harnessing the Most Complex Molecular Matrices in Nature

Beyond a biological raw material, our characterized scorpion venoms serve as a highly conserved molecular database driving breakthrough translational medicine and elite consumer bio-innovations. Validated through rigorous high-resolution analytics, our standardized assets unlock high-affinity peptides tailored for targeted oncology, neurobiology, and clinical-grade dermocosmetics.

Strategic Bio-Assets & Core Applications

From Cellular Drug Design to High-Performance Skincare and Targeted Wellness Formulations.

Androctonus crassicauda

A high-affinity native matrix engineered for advanced oncology research, serving as a primary template for selective cell-proliferation control and targeted therapeutic screening.

Hottentotta saulcyi

Distinguished by an exceptionally rich proteomics fingerprint exceeding 80% total protein content, serving as an optimal matrix for recombinant peptide extraction and ion-channel pharmacology.

Hemiscorpius lepturus

Harnessing unique Hemicalcin and Hemilipin fractions to modulate intracellular signaling, underpinning next-generation cellular skin protection and anti-aging aesthetic formulations.

Odontobuthus doriae

Rich in specialized OD1 peptides that modulate Nav1.7 sodium channels; a critical biological asset driving innovations in neurobiology and non-addictive, localized pain-relief patches.

Mesobuthus eupeus

Sourcing the distinct MeVAMP anti-infective family and chlorotoxin scaffolds, optimizing targeted bio-delivery systems for clinical research and protective dermo-cosmetic serums.

The Bio-Industrial Pipeline Grid

Where peer-reviewed venomics meets scalable, batch-traceable B2B supply chains.

Raw Bio-Assets (Liquid & Lyophilized) Published in Toxins

Standardized Crude Venom

Ultra-pure, batch-traceable native matrices standardized via high-resolution HPLC-PDA. Engineered to guarantee absolute molecular consistency for global pharmaceutical screening.

Targeted Lead Discovery

Venom-Derived Peptides

Specialized peptide platforms, including OD1 and MeVAMP families, verified by high-resolution mass spectrometry. Mapped to selectively modulate voltage-gated ion channels (Nav1.7) for non-addictive pain care and targeted oncology drug design.

Clinical Skincare & Tissue Wellness GC-MS & Clinical Tested

Characterized Scorpion Oil & Topicals

Premium lipid-peptide complexes optimized for cellular skin barrier protection, anti-aging aesthetics, and localized transdermal anti-inflammatory support. Ready for high-end private-label deployment.

Contract Research & Screening Platform LC-MS/MS, Raman, SDS-PAGE

Advanced Analytical Services

Providing independent molecular fingerprinting, lot-specific Certificates of Analysis (CoA), purity screening, and multi-disciplinary bio-assays to accelerate cross-border biotechnology validations.